Form 4: Orgenesis CFO Victor Miller Acquires 200,000 Stock Options

Orgenesis Inc.'s CFO, Victor Miller, acquired 200,000 stock options on June 27, 2024, according to a recent SEC filing.

Summary

• Victor Miller, the CFO of Orgenesis Inc., acquired 200,000 stock options on June 27, 2024.
• The exercise price of these options is $0.63.
• The options vest equally over the next 16 quarters, starting June 30, 2024, with the first vesting of 12,500 options.
• The vesting is contingent upon Miller's continued service with the company.
• The options expire on June 27, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard executive compensation disclosure. The grant of options is generally viewed as a positive, aligning management with shareholder interests, but it's not overwhelmingly positive.

Positives

• The acquisition of stock options by the CFO could align his interests with those of the shareholders, incentivizing him to improve the company's performance.

Future Outlook

The vesting of the options is contingent upon the reporting person's continued service through the applicable vesting dates.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the option grant as a positive sign, aligning management's interests with the company's long-term success.

Key Dates

Keywords

stock options, Orgenesis, Victor Miller, CFO, acquisition, vesting, SEC Form 4